Omnicell (OMCL) Capital Expenditures Growth (3y) (2013 - 2026)

Omnicell (OMCL) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -16.04%
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 11.49%
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 411.55%
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 60.17%
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 15.83%
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 Omnicell 1.70 Bn 1.41 Bn 152.94 Mn -8.40%

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.40%
Mar 31, 2026 -43.93%
Dec 31, 2025 27.15%
Sep 30, 2025 -42.45%
Jun 30, 2025 88.32%
Mar 31, 2025 9.69%
Dec 31, 2024 261.72%
Sep 30, 2024 133.36%
Jun 30, 2024 -68.13%
Mar 31, 2024 30.49%
Dec 31, 2023 -50.37%
Sep 30, 2023 64.82%
Jun 30, 2023 -27.70%
Mar 31, 2023 -22.56%
Dec 31, 2022 -106.36%
Sep 30, 2022 238.29%
Jun 30, 2022 34.96%
Mar 31, 2022 -34.81%
Dec 31, 2021 -36.07%
Sep 30, 2021 86.28%